What Is Chronic Spontaneous Urticaria? Dermatologists Explain
Chronic spontaneous urticaria is an inflammatory skin disease that causes hives that last for at least six weeks. Derms ...
Jasper Therapeutics: Briquilimab's Potential In Chronic Urticaria And Asthma
Jasper Therapeutics faces financial challenges but strong buy ratings. Read why JSPR stock is poised for growth amid risks ...
MedPage Today11d
For Your Patients: How Well Is Your Hives Treatment Working?
The higher the score, the greater the impact of hives. The Dermatology Life Quality Index or DLQI is another questionnaire used to evaluate the impact of skin disease, because patients with other ...
GlobalData on MSN3d
FDA reviews Sanofi and Regeneron’s Dupixent label expansion for urticaria
The FDA has accepted Sanofi and Regeneron’s application to expand Dupixent’s use, with a decision expected by April 2025.
Managed Healthcare Executive3d
FDA Sets Date For Resubmitted Dupixent in Inflammatory Skin Disease
The FDA has provided a date of April 18, 2025, to review the application for Dupixent to treat patients with chronic ...